Skip to main content
. 2019 Jul;22(7):752–758. doi: 10.22038/ijbms.2019.33892.8064

Figure 2.

Figure 2

Anticonvulsant effect of apigenin (50 mg/kg/day). Following apigenin treatment, decrease in the onset of seizure (P<0.05; A), average seizure intensity (P<0.01; B), latency to the tonic-clonic stage (P<0.001; C), and duration time in tonic-clonic stage (P<0.01; D) were recorded. The data represented as the mean±SEM, statistically significant differences compared with KA group